Lonza Group has been a dominant player in the contract development and manufacturing space for decades. We think the outlook for Lonza looks bright, especially as drug manufacturing becomes more ...

The Australian market has been showing positive momentum, with the ASX200 up 0.49% as investor sentiment is buoyed by expectations of an RBA rate cut. In such a climate, identifying stocks that ...